The growth of Viagra and its impact on the pharmaceutical landscape presents a intricate question for traders. While the first sales figures were astounding, the intellectual property has lapsed, leading to a deluge of generic alternatives that are chipping away at profit. Moreover, the market is facing issues related to demographic trends and chan